0001562180-22-003666.txt : 20220503
0001562180-22-003666.hdr.sgml : 20220503
20220503161448
ACCESSION NUMBER: 0001562180-22-003666
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220501
FILED AS OF DATE: 20220503
DATE AS OF CHANGE: 20220503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Derakhshan Behrad
CENTRAL INDEX KEY: 0001853109
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 22887023
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: 303-735-8373
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-05-01
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001853109
Derakhshan Behrad
C/O EDGEWISE THERAPEUTICS, INC.
3145 COLORADO AVE.
BOULDER
CO
80303
false
true
false
false
Chief Business Officer
Restricted Stock Units
0.00
2022-05-01
4
A
false
15625.00
0.00
A
2025-05-01
Common Stock
15625.00
15625.00
D
RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023.
/s/ John R Moore Attorney-in-Fact for Behrad Derakhshan
2022-05-03